Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons - Wikidata - wikimedia - TriplyDB

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

http://www.wikidata.org/entity/Q24652687

about

PPAR-gamma: Therapeutic Potential for Multiple Sclerosis Arf4 determines dentate gyrus-mediated pattern separation by regulating dendritic spine development Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders Aberrant insulin signaling in Alzheimer's disease: current knowledge Thiazolidinediones promote axonal growth through the activation of the JNK pathway PPAR Gamma in Neuroblastoma: The Translational Perspectives of Hypoglycemic Drugs Small-molecule structure correctors target abnormal protein structure and function: structure corrector rescue of apolipoprotein E4-associated neuropathology Structure-dependent impairment of intracellular apolipoprotein E4 trafficking and its detrimental effects are rescued by small-molecule structure correctors ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo.Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice.Small molecule structure correctors abolish detrimental effects of apolipoprotein E4 in cultured neurons.Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directions Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases.Cellular source-specific effects of apolipoprotein (apo) E4 on dendrite arborization and dendritic spine development.Protection of neurons and microglia against ethanol in a mouse model of fetal alcohol spectrum disorders by peroxisome proliferator-activated receptor-γ agonists.Neurotrophin-mediated dendrite-to-nucleus signaling revealed by microfluidic compartmentalization of dendrites An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.Entorhinal cortical neurons are the primary targets of FUS mislocalization and ubiquitin aggregation in FUS transgenic rats.Apolipoprotein e sets the stage: response to injury triggers neuropathology.PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.A look inside the diabetic brain: Contributors to diabetes-induced brain aging.Troglitazone reverses the multiple drug resistance phenotype in cancer cells.Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?The Potential Role of Insulin on the Shank-Postsynaptic Platform in Neurodegenerative Diseases Involving Cognition.Role of PPAR γ in the Differentiation and Function of Neurons PPARγ ligands and their therapeutic applications: a patent review (2008 - 2014).The Complex Role of Apolipoprotein E in Alzheimer's Disease: an Overview and Update.Alzheimer's disease: diagnostics, prognostics and the road to prevention.Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS.Impact of the Reelin signaling cascade (ligands-receptors-adaptor complex) on cognition in schizophrenia.Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.

P2860

Q21342822-38B49AC6-2492-4CB1-A0C5-B5288328E2C3 Q24300583-5AC35C3C-6655-4D48-BCBC-8CCBD10B22CB Q24604376-A4760EAF-4149-4149-B5D1-B683B4DD5150 Q26747482-1DFEC4A0-EE88-439B-892A-0A14C69DB91C Q27024222-08153911-850E-44D2-BABB-FADAED9B0AF0 Q27317282-E80EFE90-3F3C-4F3C-9456-8DFEE6B5ADCD Q28066756-9F067442-839D-49FD-B04A-4DE46635525D Q30421643-E30A07F6-9D2B-4046-91A3-B87F81669F0A Q30500121-F8229B54-2F3A-4A27-85DB-8008022EEA11 Q33758196-1FE5B405-A22D-4DEB-99D5-39D191718C15 Q33819768-1B4254B2-5AE8-4443-9AC6-BB3A943A01E9 Q34096644-140F145E-3FC3-440B-98AC-BB834AB454DC Q34135724-6FBBF387-530F-4A26-9836-21DE2B900CBF Q34621541-5D5E3B63-5A73-46E6-82CC-2919A03D634C Q34635216-886058AC-58A7-4AA9-BBBB-F1AACEB57BA9 Q35015002-4E31FAC8-24A4-4A9B-91B7-2C3C1D37FACD Q35090893-A413E697-EDDF-4A86-AFD2-162FB09012A1 Q35117334-BCA17DEC-CFC0-41A3-A8DA-A6709BB745D6 Q35132162-71850B95-FAB2-4159-96A8-BF6B64E464CD Q36317708-C367E78A-84E2-40FC-8B9D-BD85B9635880 Q36963238-13346B48-FA60-4B2C-B071-C28A114D9E5E Q37215869-C3D06682-CA25-43C2-9B94-5774DA5CAFF0 Q37330771-745F43BA-226E-439E-AA48-7FC14C17003C Q37403238-AA217886-6FDC-4F45-8E48-B7CF0ABB3544 Q37783637-F7803A9F-FEC7-4FE0-8104-8D31E9C75208 Q38178230-CCD4598D-FE2E-43A7-AA8D-EF249F1A5A0F Q38253356-78BA1C66-0DC3-4753-839D-0323D005DF6E Q38270503-5BA3224B-119F-4EC9-AF32-F5608C17D533 Q38959290-AC006123-DDEA-4A42-81D2-85CF1CF40B15 Q41731898-68E5CBC2-C555-46F7-BBFF-F83766E4E6A0 Q43138847-8E9A3E8A-2526-47B9-9166-99397192DF86 Q45065209-B2DA7785-5672-41A6-A64D-24B626DB5B21 Q45924406-F015D00F-D8D4-4406-916A-2572FF440B28 Q46019370-D76E89F9-3973-4D20-9B88-7FDD90DEC363 Q51481172-8F4012F0-9619-4B9B-AD19-AC94AD080D19

P2860

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

http://www.wikidata.org/entity/Q24652687

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@ast

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@en

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@nl

type

label

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@ast

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@en

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@nl

prefLabel

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@ast

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@en

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@nl

P1433

Q24652687-F2A5A74A-9A39-48EA-9138-7801F726E58A

P1476

Q24652687-FFE3AD70-5E65-47E9-830F-3D515C5FC630

P2093

Q24652687-6EB6BBB8-3C0E-4E34-8BE7-C001227607F0

Q24652687-A1EA058F-C9DD-4687-8AF1-13D693939A2E

Q24652687-BB0277EF-6E03-4B53-A558-A91220797674

Q24652687-F559C060-49E2-4E44-86E4-3834E0ACDF80

Q24652687-FC3074C5-6388-426C-A027-66D2E1D0FCD3

Q24652687-FD5E4F41-B821-4A72-AB75-DFC07450C9A4

P2860

Q24652687-064C0341-0D0B-4385-B2C9-8035DE6CB33A

Q24652687-09A6D60C-F34A-4A69-B518-8CF5CCB6B246

Q24652687-0A3E8E38-0DE0-42F8-A597-4137F2C43CD0

Q24652687-0B8AA493-B3BF-4FE8-891D-90AC8C3B4383

Q24652687-11FCCDC3-643B-42C9-98D3-C48B6564B19F

Q24652687-1340D5F6-471A-42BC-AF8C-D6BBF118C481

Q24652687-1952FC7D-CBE4-4AA8-9E4D-E534D30410A0

Q24652687-1F3DA9D1-0C47-4E4C-87F6-F677B66EEE64

Q24652687-23314DFD-F8FA-4B50-8718-9492739D817E

Q24652687-2656F23A-9352-43C2-8AD9-345480C10110

P304

Q24652687-A355D0DE-4044-4453-8505-FE8E3A28CF57

P31

Q24652687-B275EF0E-BA24-4411-AEF0-5479F1687542

P3181

Q24652687-B4627B86-DA4F-4D28-8407-E52CFB5AF6C8

P356

Q24652687-77E8F29C-D67D-4964-A99F-D9A3BF6BE4A1

P407

Q24652687-5FC314B9-F1E6-457F-9E3D-61024483D94E

P433

Q24652687-7271867F-3E7E-406F-93D7-621E3A619809

P478

Q24652687-59257531-DF29-4D1E-B9D4-36CE6E71F73C

P577

Q24652687-912F1BE0-5B5C-4836-AE7C-61273643A96A

P5875

Q24652687-2761931C-52B0-4485-A39E-D652040B7CF9

P698

Q24652687-91FCBAB3-24A3-4974-B1A3-C99BD8834FC2

P932

Q24652687-8D631341-7D62-40B1-8E37-4D7116BF1141

P3181

P356

PNAS.0709906104

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Rosiglitazone increases dendri ...... E4 in primary cortical neurons

@en

P2093

Allen D Roses

http://www.w3.org/2001/XMLSchema#string

Ann M Saunders

http://www.w3.org/2001/XMLSchema#string

Jens Brodbeck

http://www.w3.org/2001/XMLSchema#string

Maureen E Balestra

http://www.w3.org/2001/XMLSchema#string

Robert W Mahley

http://www.w3.org/2001/XMLSchema#string

Yadong Huang

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation

P304

1343-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

928853

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.0709906104

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5639866

http://www.w3.org/2001/XMLSchema#string

P698

18212130

http://www.w3.org/2001/XMLSchema#string

P932

2234140

http://www.w3.org/2001/XMLSchema#string